APM
WST icon

Advanced Portfolio Management’s West Pharmaceutical WST Stock Holding History

Advanced Portfolio Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,238
Closed -$436K – 83
2023
Q4 		$436K Buy
+1,238
New +$438K 0.46% 58

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Advanced Portfolio Management's WST Position: Q1 2024 in Review

Advanced Portfolio Management sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 1,238 shares — an estimated $436K sold.

Advanced Portfolio Management first reported a position in WST in Q4 2023 and held it in 1 quarter. The position peaked at $436K in Q4 2023. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Advanced Portfolio Management reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Advanced Portfolio Management sold 1,238 West Pharmaceutical shares in Q1 2024, an estimated $436K.
  • Advanced Portfolio Management first reported a position in West Pharmaceutical in Q4 2023 and held it in 1 quarter.
  • Advanced Portfolio Management's West Pharmaceutical position peaked at $436K in Q4 2023.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Advanced Portfolio Management's 13F filing for Q1 2024, filed 15 May 2024.